Hopstem
Hangzhou
About Hopstem
Hopstem is a Hangzhou-based pharmaceutical company, engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $42.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2021)
- Website: hopstem.com
- Phone: 0571-88197776
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/hopstem-80982 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.